In 2026, the estimated revenue loss for pharmaceuticals in the United States due to the Inflation Reduction Act (IRA) was ** billion U.S. dollars. The loss is likely to increase ** by 2035.Â
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
EY. (December 12, 2025). Estimated annual revenue loss for pharmaceuticals in the U.S. from 2026 to 2035 (in billion U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 29, 2026, from /statistics/1662170/annual-revenue-loss-for-pharma-in-the-us/
EY. "Estimated annual revenue loss for pharmaceuticals in the U.S. from 2026 to 2035 (in billion U.S. dollars)." Chart. December 12, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 29, 2026. /statistics/1662170/annual-revenue-loss-for-pharma-in-the-us/
EY. (2025). Estimated annual revenue loss for pharmaceuticals in the U.S. from 2026 to 2035 (in billion U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 29, 2026. /statistics/1662170/annual-revenue-loss-for-pharma-in-the-us/
EY. "Estimated Annual Revenue Loss for Pharmaceuticals in The U.S. from 2026 to 2035 (in Billion U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 12 Dec 2025, /statistics/1662170/annual-revenue-loss-for-pharma-in-the-us/
EY, Estimated annual revenue loss for pharmaceuticals in the U.S. from 2026 to 2035 (in billion U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1662170/annual-revenue-loss-for-pharma-in-the-us/ (last visited July 29, 2026)
Estimated annual revenue loss for pharmaceuticals in the U.S. from 2026 to 2035 (in billion U.S. dollars) [Graph], EY, December 12, 2025. [Online]. Available: /statistics/1662170/annual-revenue-loss-for-pharma-in-the-us/
